Literature DB >> 27085625

Renal Mass Biopsy: Always, Sometimes, or Never?

Alexander Kutikov1, Marc C Smaldone2, Robert G Uzzo2, Miki Haifler2, Gennady Bratslavsky3, Bradley C Leibovich4.   

Abstract

Renal mass biopsy is a useful clinical tool; nevertheless, in a majority of patients, renal mass biopsy in its current form does not alter clinical management. Its routine use in all-comers is not indicated outside of clinical protocols.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2016        PMID： 27085625     DOI： 10.1016/j.eururo.2016.04.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  16 in total

1.  Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses.

Authors:  Patrick O Richard; Lisa Martin; Luke T Lavallée; Philippe D Violette; Maria Komisarenko; Andrew J Evans; Kunal Jain; Michael A S Jewett; Antonio Finelli
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

2.  Kidney cancer: Emerging guidelines for managing small renal masses.

Authors:  Benjamin T Ristau; Marc C Smaldone
Journal:  Nat Rev Urol       Date:  2017-03-14       Impact factor: 14.432

Review 3.  Kidney cancer: Undertreatment of small renal masses by overuse of biopsy.

Authors:  Hiten D Patel; Phillip M Pierorazio
Journal:  Nat Rev Urol       Date:  2016-11-02       Impact factor: 14.432

Review 4.  Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors:  Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

5.  Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses.

Authors:  Noah E Canvasser; Fernando U Kay; Yin Xi; Daniella F Pinho; Daniel Costa; Alberto Diaz de Leon; Gaurav Khatri; John R Leyendecker; Takeshi Yokoo; Aaron Lay; Nicholas Kavoussi; Ersin Koseoglu; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  J Urol       Date:  2017-04-28       Impact factor: 7.450

6.  Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.

Authors:  Brett A Johnson; Sandy Kim; Ryan L Steinberg; Alberto Diaz de Leon; Ivan Pedrosa; Jeffrey A Cadeddu
Journal:  Urol Oncol       Date:  2019-09-17       Impact factor: 3.498

7.  The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Authors:  Jennifer Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

Review 8.  Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation.

Authors:  Alejandro Sanchez; Adam S Feldman; A Ari Hakimi
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

9.  Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.

Authors:  Ryan L Steinberg; Robert G Rasmussen; Brett A Johnson; Rashed Ghandour; Alberto Diaz De Leon; Yin Xi; Takeshi Yokoo; Sandy Kim; Payal Kapur; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  Eur Radiol       Date:  2020-08-08       Impact factor: 5.315

Review 10.  Surveillance for low-risk kidney cancer: a narrative review of contemporary worldwide practices.

Authors:  Helen Wei Cui; Mark Edward Sullivan
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.